CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

The Lancet
Original article

[Comment] A novel unimolecular GLP1 and amylin receptor agonist for glucose and weight control

Related Companies

Read the original article

Published by The Lancet on July 30, 2026 10:30 PM

Read Original